Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-025933

See Remarks bought 43,360 shares at $11.35 ($492,028)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sapir Alex See Remarks 2024-03-04 Purchase +43,360 $11.35 $492,028 43,360 D
Open-market purchases · 43,360 sh · avg $11.35 · $492,028
Loading xslF345X05/ownership.xml…